the benefits of tucatinib in her2 breast cancer
Published 3 years ago • 151 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
3:15
a close look at tucatinib in her breast cancer
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
0:51
dr. hamilton discusses tucatinib in her2 breast cancer
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
0:45
dr. robson on the potential utility of tucatinib in her2 breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
1:45
dr. chien on tucatinib in her2 breast cancer
-
17:53
dr. murthy on the clinical implications of tucatinib approval in her2 breast cancer
-
1:21
dr. park on the benefit of trastuzumab deruxtecan in her2 breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
0:34
copy of dr. chien on tucatinib in her2 breast cancer
-
3:44
her2 breast cancer: brain metastasis prevalence & later-line therapy
-
3:48
her2 breast cancer: future treatment landscape
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer